Programming Biology: Inside the DNA Supply Chain Powering Modern Drug Discovery - Dr. Patrick Finn, Ph.D. - President & COO -Twist Bioscience

Episode notes

Send us Fan Mail We used to think of DNA as something we read. Now we’re starting to treat it like something we write - and that changes everything about how medicine gets made. Dr. Patrick Finn, Ph.D. is President and COO of Twist Bioscience ( ), a company that’s helping turn biology into something you can engineer, iterate, and even industrialize. Dr. Finn has spent his entire career building the infrastructure layer of modern biotech - from sequencing and sample prep at Beckman Coulter and Invitrogen, to scaling commercial platforms at Agilent Technologies and now Twist. Dr. Finn also served as Vice President of Sales and Marketing for Enzymatics (recently acquired by QIAGEN), leading commercial activities for North America and Europe, delivering significant top line growth and expanding the base of business to business customers. So this isn’t just a conversation about the future - it’s about how the tools that make the future possible are actually built and deployed. On this episode we go beyond the buzzwords and dig into what it really means to “program biology”, and how close we actually are to designing medicines the way we design software.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

• The Race to Build the Next Trillion-Dollar AI Chip CompanyTechSurge: Deep Tech Podcast · on Artificial intelligence90 / 100
• Less about Models; More about ArchitecturePractical AI · on Artificial intelligence85 / 100
• How Consumers Are Defining Healthcare's Future w/ Dr. Daniel Kraft, Founder, NextMed HealthCareTalk: Healthcare. Unfiltered. · on AI in healthcare81 / 100
• Code Review Is a Taste Problem | David Poll ⁨@GitHub⁩Hangar DX Podcast · on Artificial intelligence81 / 100
• 321 | How to Build an AI App Without Coding: From Idea to App Store with Replit & Claude by Bryce Rattner KeithleyLeveraging AI · on Artificial intelligence80 / 100
• Rapid Response: OpenAI’s Critterz blowback - Director Nik Kleverov on year zero for HollywoodPioneers of AI · on Artificial intelligence76 / 100

• Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100
• Inside the Global Biotech Ecosystem - Where Innovation Goes Next | Sara Jane Demy - Founder and CEO, Demy-Colton
• Reversing Cellular Age: The Scientist Who Helped Create iPS Cells Reveals What’s Next - Dr. Koji Tanabe, Ph.D. - Founder and CEO, I Peace Inc.
• The End of High Cholesterol? The First Oral PCSK9 Drug Could Change Heart Medicine Forever - Dr. Norman Lepor, MD - Founder and Director, National Heart Institute
• The Hidden Heart Risk: Amgen’s Dr. Paul Burton on the Future of Preventing Heart Attacks - Dr. Paul Burton, M.D., Ph.D., F.A.C.C., M.R.C.S., F.R.C.P. - Senior Vice President and Chief Medical Officer - Amgen